No Data
No Data
Express News | Cormorant diagnosis: Shareholder Shanghai Peixi and its concerted action person HJ CAPITAL's shareholding ratio decreased to 8.77%.
Komei Diagnostic Technology Co., Ltd. 2024 Semi-Annual Report
Summary of the 2024 semi-annual report of Komei Diagnostic Technology Co., Ltd.
Express News | Kemei Diagnostics: net income of 76.6423 million yuan in the first half of the year
Express News | Kemei Diagnosis: Shareholder Hengqin Junlian Zhi Kang and its concerted action person, LOYAL CLASS, collectively reduced their holdings to 6.99%.
Kemei Diagnosis (688468.SH): has repurchased 1.62% of the company's shares.
On July 31st, GeLongHui reported that Kemei Diagnosis (688468.SH) has cumulatively repurchased 6.5149 million shares of the company through the Shanghai Stock Exchange trading system as of July 31, 2024, accounting for 1.62% of the company's total share capital of 401,108,000 shares, with a highest repurchase price of RMB 10.30/share and a lowest price of RMB 5.83/share. The total amount paid for the repurchase is RMB 51.0751 million yuan (excluding transaction fees such as stamp duty and commission).
No Data